| 1. Kotick MP, Leland DL, Polazzi JO, Howes JF, Bousquet A.. (1983) Analgesic narcotic antagonists. 15. Potent narcotic agonist 7 beta-(arylalkyl)-4,5 alpha-epoxymorphinans., 26 (7): [PMID:6864732] [10.1021/jm00361a019] |
| 2. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 3. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2004) Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics., 47 (5): [PMID:14971904] [10.1021/jm030408h] |
| 4. Mohacsi E, Leimgruber W, Baruth H.. (1982) Synthesis and pharmacology of metabolically stable tert-butyl ethers of morphine and levorphanol., 25 (10): [PMID:6292420] [10.1021/jm00352a037] |
| 5. Leland DL, Kotick MP.. (1980) Analgesic narcotic antagonists. 4. 7-Methyl-N-(cycloalkylmethyl)-3-hydroxymorphinan-6-ones and -isomorphinan-6-ones., 23 (12): [PMID:7192744] [10.1021/jm00186a025] |
| 6. Kotick MP, Leland DL, Polazzi JO, Howes JF, Bousquet AR.. (1981) Analgesic narcotic antagonists. 8. 7 alpha-Alkyl-4,5 alpha-epoxymorphinan-6-ones., 24 (12): [PMID:7310822] [10.1021/jm00144a015] |
| 7. Polazzi JO, Schut RN, Kotick MP, Howes JF, Osgood PF, Razdan RK, Villarreal JE.. (1980) Analgesic narcotic antagonists. 2. 8-Alkymorphinan-6-ones., 23 (2): [PMID:6767032] [10.1021/jm00176a013] |
| 8. May EL.. (1980) Third Smissman Award address: reminiscences and musings of a classical medicinal chemist., 23 (3): [PMID:7365738] [10.1021/jm00177a001] |
| 9. Lombardo F, Shalaeva MY, Tupper KA, Gao F.. (2001) ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds., 44 (15): [PMID:11448232] [10.1021/jm0100990] |
| 10. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 11. May EL.. (1992) Alfred Burger Award address. A half century in medicinal chemistry with major emphasis on pain-relieving drugs and their antagonists., 35 (20): [PMID:1433169] [10.1021/jm00098a001] |
| 12. McNeal ET, Lewandowski GA, Daly JW, Creveling CR.. (1985) [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs., 28 (3): [PMID:2579237] [10.1021/jm00381a019] |
| 13. Musso DL, Cochran FR, Kelley JL, McLean EW, Selph JL, Rigdon GC, Orr GF, Davis RG, Cooper BR, Styles VL, Thompson JB, Hall WR.. (2003) Indanylidenes. 1. Design and synthesis of (E)-2-(4,6-difluoro-1-indanylidene)acetamide, a potent, centrally acting muscle relaxant with antiinflammatory and analgesic activity., 46 (3): [PMID:12540239] [10.1021/jm020067s] |
| 14. Avdeef A, Barrett DA, Shaw PN, Knaggs RD, Davis SS.. (1996) Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates., 39 (22): [PMID:8893832] [10.1021/jm960073m] |
| 15. Hanessian S, Parthasarathy S, Mauduit M, Payza K.. (2003) The power of visual imagery in drug design. Isopavines as a new class of morphinomimetics and their human opioid receptor binding activity., 46 (1): [PMID:12502358] [10.1021/jm020164l] |
| 16. Flouzat C, Bresson Y, Mattio A, Bonnet J, Guillaumet G.. (1993) Novel nonopioid non-antiinflammatory analgesics: 3-(aminoalkyl)- and 3-[(4-aryl-1-piperazinyl)alkyl]oxazolo[4,5-b]pyridin-2(3H)-ones., 36 (4): [PMID:8386248] [10.1021/jm00056a010] |
| 17. Cheney BV.. (1988) Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptor., 31 (3): [PMID:2831361] [10.1021/jm00398a007] |
| 18. Awaya H, May EL, Aceto MD, Merz H, Rogers ME, Harris LS.. (1984) Racemic and optically active 2,9-dimethyl-5-(m-hydroxyphenyl)morphans and pharmacological comparison with the 9-demethyl homologues., 27 (4): [PMID:6708055] [10.1021/jm00370a019] |
| 19. Harris A, Middlemiss D, Mills K, Gower AJ, Tyers MB.. (1983) Synthesis of exo-3-phenylbicyclo[3.2.1]oct-3-en-2-amine and related compounds as potential analgesics., 26 (1): [PMID:6681842] [10.1021/jm00355a012] |
| 20. McKenzie TC, Epstein JW, Fanshawe WJ, Dixon JS, Osterberg AC, Wennogle LP, Regan BA, Abel MS, Meyerson LR.. (1984) 5-Aryl-3-azabicyclo[3.2.0]heptan-6-one ketals, compounds with morphine-like analgesic activity., 27 (5): [PMID:6325691] [10.1021/jm00371a012] |
| 21. Leland DL, Kotick MP.. (1981) Analgesic narcotic antagonists. 5. 7,7-Dimethyldihydrocodeinones and 7,7-dimethyldihydromorphinones., 24 (6): [PMID:6166748] [10.1021/jm00138a015] |
| 22. Kotick MP.. (1981) Analgesic narcotic antagonists. 6. 7 beta, 8 beta-Methano- and 7 beta, 8 beta-epoxydihydrocodeinone., 24 (6): [PMID:6114178] [10.1021/jm00138a016] |
| 23. Venhorst J, ter Laak AM, Commandeur JN, Funae Y, Hiroi T, Vermeulen NP.. (2003) Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities., 46 (1): [PMID:12502361] [10.1021/jm0209578] |
| 24. Tobita M, Nishikawa T, Nagashima R.. (2005) A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors., 15 (11): [PMID:15911273] [10.1016/j.bmcl.2005.03.080] |
| 25. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 26. Moda TL, Montanari CA, Andricopulo AD.. (2007) Hologram QSAR model for the prediction of human oral bioavailability., 15 (24): [PMID:17870541] [10.1016/j.bmc.2007.08.060] |
| 27. Metcalf MD, Aceto MD, Harris LS, Woods JH, Traynor JR, Coop A, May EL.. (2008) The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans., 16 (2): [PMID:17962026] [10.1016/j.bmc.2007.10.030] |
| 28. Nikolaev VO, Boettcher C, Dees C, Bünemann M, Lohse MJ, Zenk MH.. (2007) Live cell monitoring of mu-opioid receptor-mediated G-protein activation reveals strong biological activity of close morphine biosynthetic precursors., 282 (37): [PMID:17616524] [10.1074/jbc.m703272200] |
| 29. Cunningham CW, Mercer SL, Hassan HE, Traynor JR, Eddington ND, Coop A.. (2008) Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs., 51 (7): [PMID:18311899] [10.1021/jm701457j] |
| 30. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 31. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725] [10.1021/jm8003152] |
| 32. Ho GD, Anthes J, Bercovici A, Caldwell JP, Cheng KC, Cui X, Fawzi A, Fernandez X, Greenlee WJ, Hey J, Korfmacher W, Lu SX, McLeod RL, Ng F, Torhan AS, Tan Z, Tulshian D, Varty GB, Xu X, Zhang H.. (2009) The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety., 19 (9): [PMID:19339177] [10.1016/j.bmcl.2009.03.031] |
| 33. Yang SW, Ho G, Tulshian D, Greenlee WJ, Tan Z, Zhang H, Smith-Torhan A, Fawzi A, Anthes J, Lu S, Varty G, Fernandez X, McLeod RL, Hey J.. (2009) Identification of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the management of cough and anxiety., 19 (9): [PMID:19332374] [10.1016/j.bmcl.2009.03.057] |
| 34. Jiang Y, Li H, Li P, Cai Z, Ye W.. (2005) Steroidal alkaloids from the bulbs of Fritillaria puqiensis., 68 (2): [PMID:15730259] [10.1021/np0497649] |
| 35. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 36. Yang SW, Ho G, Tulshian D, Greenlee WJ, Anthes J, Fernandez X, McLeod RL, Hey JA, Xu X.. (2009) Discovery of orally active 3-pyridinyl-tropane as a potent nociceptin receptor agonist for the management of cough., 52 (17): [PMID:19678644] [10.1021/jm9008218] |
| 37. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
| 38. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
| 39. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 40. Talevi A, Goodarzi M, Ortiz EV, Duchowicz PR, Bellera CL, Pesce G, Castro EA, Bruno-Blanch LE.. (2011) Prediction of drug intestinal absorption by new linear and non-linear QSPR., 46 (1): [PMID:21112128] [10.1016/j.ejmech.2010.11.005] |
| 41. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 42. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, |
| 43. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, |
| 44. Fridén M, Winiwarter S, Jerndal G, Bengtsson O, Wan H, Bredberg U, Hammarlund-Udenaes M, Antonsson M.. (2009) Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids., 52 (20): [PMID:19764786] [10.1021/jm901036q] |
| 45. Tukey RH, Strassburg CP.. (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease., 40 (1): [PMID:10836148] [10.1146/annurev.pharmtox.40.1.581] |
| 46. Kiang TK, Ensom MH, Chang TK.. (2005) UDP-glucuronosyltransferases and clinical drug-drug interactions., 106 (1): [PMID:15781124] [10.1016/j.pharmthera.2004.10.013] |
| 47. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 48. Nepali K, Bande MS, Sapra S, Garg A, Kumar S, Sharma P, Goyal R, Satti NK, Suri OP, Dhar KL. (2012) Antitussive effects of azepino[2,1-b]quinazolones, 21 (7): [10.1007/s00044-011-9641-1] |
| 49. Noorizadeh H, Noorizadeh M, Farmany A. (2012) Advanced QSRR models of toxicological screening of basic drugs in whole blood by UPLC-TOFMS, 21 (12): [10.1007/s00044-012-9977-1] |
| 50. Raffa RB, Beckett JR, Brahmbhatt VN, Ebinger TM, Fabian CA, Nixon JR, Orlando ST, Rana CA, Tejani AH, Tomazic RJ.. (2013) Orally active opioid compounds from a non-poppy source., 56 (12): [PMID:23517479] [10.1021/jm400143z] |
| 51. Settimo L, Bellman K, Knegtel RM.. (2013) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds., [PMID:24249037] [10.1007/s11095-013-1232-z] |
| 52. Antonilli L, Togna AR, Sabatini G, Venditti A, Guarcini L, Togna GI, Nicoletti R, Sanasi F, Bianco A, Nencini P.. (2013) Pivaloylcodeine, a new codeine derivative, for the inhibition of morphine glucuronidation. An in vitro study in the rat., 21 (24): [PMID:24183585] [10.1016/j.bmc.2013.09.062] |
| 53. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
| 54. PubChem BioAssay data set, |
| 55. Mazzocchi PH, Stahly BC.. (1979) Synthesis and pharmacological activity of 2,3,4,5,-tetrahydro-1,5-methano-1H-3-benzazepines., 22 (4): [PMID:430484] [10.1021/jm00190a020] |
| 56. Waters JA.. (1977) Pyrrole esters of tropanols and related structures as analgesics., 20 (8): [PMID:408488] [10.1021/jm00218a021] |
| 57. Mazzocchi PH, Harrison AM.. (1978) Synthesis and analgetic activity of 1,2,3,4,5,6-hexahydro-1,6-methano-3-benzozocines., 21 (2): [PMID:413922] [10.1021/jm00200a021] |
| 58. Clark RL, Pessolano AA, Shen TY, Jacobus DP, Jones H, Lotti VJ, Flataker LM.. (1978) Synthesis and analgesic activity of 1,3-dihydro-3-(substituted phenyl)imidazo[4,5-b]pyridin-2-ones and 3-(substituted phenyl)-1,2,3-triazolo[4,5-b]pyridines., 21 (9): [PMID:309950] [10.1021/jm00207a023] |
| 59. Matharu SS, Rowlands DA, Taylor JB, Westwood R.. (1977) Synthesis and antitussive activity of aminotetra- (and -hexa-) hydrodibenzofurans., 20 (2): [PMID:836490] [10.1021/jm00212a003] |
| 60. Waters JA.. (1978) Aromatic esters of nonquaternary carbon-4 piperidinols as analgesics., 21 (7): [PMID:209187] [10.1021/jm00205a007] |
| 61. Rice KC, Jacobson AE.. (1976) Optical resolution of (+/-)-2,5-dimethyl-2'-hydroxy-9alpha- and -9beta-propyl-6,7-benzomorphans and their pharmacological properties., 19 (3): [PMID:815550] [10.1021/jm00225a021] |
| 62. Waters JA.. (1977) Heterocyclic and piperonylic acid esters of 1-methyl-4-piperidinol as analgesics., 20 (11): [PMID:199728] [10.1021/jm00221a027] |
| 63. Fridén M, Bergström F, Wan H, Rehngren M, Ahlin G, Hammarlund-Udenaes M, Bredberg U.. (2011) Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods., 39 (3): [PMID:21149540] [10.1124/dmd.110.035998] |
| 64. Loi CM, Smith DA, Dalvie D.. (2013) Which metabolites circulate?, 41 (5): [PMID:23454828] [10.1124/dmd.112.050278] |
| 65. WHO Anatomical Therapeutic Chemical Classification, |
| 66. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 67. Unpublished dataset, |
| 68. Meyer MJ, Neumann VE, Friesacher HR, Zdrazil B, Brockmöller J, Tzvetkov MV.. (2019) Opioids as Substrates and Inhibitors of the Genetically Highly Variable Organic Cation Transporter OCT1., 62 (21): [PMID:31597043] [10.1021/acs.jmedchem.9b01301] |
| 69. Cho S, Kim SH, Shin D.. (2019) Recent applications of hydantoin and thiohydantoin in medicinal chemistry., 164 [PMID:30622025] [10.1016/j.ejmech.2018.12.066] |
| 70. Mazurov A, Ho J, Low T, Hoeng J.. (2023) Novel α7 nicotinic acetylcholine receptor modulators as potential antitussive agents., 80 [PMID:36395996] [10.1016/j.bmcl.2022.129067] |
| 71. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
